Skip to main content

Grifols SA

GRFS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001438569

No open-market purchases or sales by Grifols SA insiders were filed in the last 90 days; 164 institutions reported holding it in 13F filings for Q2 2026, worth $1.01B in total; no superinvestor holds it.

Other share classesGIFLFGIFOFGIKLY

Q1 2026 vs. Q4 2025

How the institutions holding Grifols SA changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of GRFS: Q4 2025 compared with Q1 2026
MeasureQ4 2025Of which not filed for Q1 2026Q1 2026Change
Holders1824186+8
Shares143.4M1.94M143.5M+1.95M (+1.4%)
Value$1.34B$18.1M$1.15B−$173.9M (−13.1%)

4 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (26)

Institutions that held Grifols SA at the end of Q1 2026 but not at the end of Q4 2025.

Sold out (18)

Institutions that held Grifols SA at the end of Q4 2025 and filed for Q1 2026 without it.

Not filed for Q1 2026 yet (4)

Institutions that held Grifols SA at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding GRFS in Q4 2025 that haven't filed for Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Norges Bank1,940,000$18.1M
DV Equities, LLC210$1.96K
Global Retirement Partners, LLC146$1.36K
CIBC Private Wealth Group, LLC6$56